TrialThe lancet. Gastroenterology & hepatology2022

Safety and efficacy of sofosbuvir-velpatasvir-voxilaprevir for re-treatment of chronic hepatitis C virus infection in patients with previous direct-acting antiviral treatment failure in Rwanda (SHARED-3): a single-arm trial.

Neil Gupta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.